Logo image of BRIA

BRILLIA INC-A (BRIA) Stock Fundamental Analysis

NYSEARCA:BRIA - NYSE Arca - KYG1645N1016 - Common Stock - Currency: USD

2.55  +0.28 (+12.33%)

Fundamental Rating

3

BRIA gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 17 industry peers in the Distributors industry. BRIA has an average financial health and profitability rating. BRIA is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year BRIA was profitable.
In the past year BRIA has reported a negative cash flow from operations.
BRIA Yearly Net Income VS EBIT VS OCF VS FCFBRIA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 0 2M 4M 6M 8M 10M

1.2 Ratios

BRIA has a better Return On Assets (11.94%) than 88.24% of its industry peers.
With an excellent Return On Equity value of 43.85%, BRIA belongs to the best of the industry, outperforming 94.12% of the companies in the same industry.
The Return On Invested Capital of BRIA (49.37%) is better than 94.12% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for BRIA is significantly above the industry average of 17.10%.
The 3 year average ROIC (55.82%) for BRIA is well above the current ROIC(49.37%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 11.94%
ROE 43.85%
ROIC 49.37%
ROA(3y)16.06%
ROA(5y)N/A
ROE(3y)52.81%
ROE(5y)N/A
ROIC(3y)55.82%
ROIC(5y)N/A
BRIA Yearly ROA, ROE, ROICBRIA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 20 40 60

1.3 Margins

With a decent Profit Margin value of 5.64%, BRIA is doing good in the industry, outperforming 70.59% of the companies in the same industry.
BRIA has a better Operating Margin (7.67%) than 64.71% of its industry peers.
Looking at the Gross Margin, with a value of 44.89%, BRIA belongs to the top of the industry, outperforming 82.35% of the companies in the same industry.
Industry RankSector Rank
OM 7.67%
PM (TTM) 5.64%
GM 44.89%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
BRIA Yearly Profit, Operating, Gross MarginsBRIA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 10 20 30 40

4

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so BRIA is creating value.
BRIA has about the same amout of shares outstanding than it did 1 year ago.
BRIA has a worse debt/assets ratio than last year.
BRIA Yearly Shares OutstandingBRIA Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 10M 20M 30M
BRIA Yearly Total Debt VS Total AssetsBRIA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 5M 10M 15M 20M 25M

2.2 Solvency

BRIA has an Altman-Z score of 5.76. This indicates that BRIA is financially healthy and has little risk of bankruptcy at the moment.
With a decent Altman-Z score value of 5.76, BRIA is doing good in the industry, outperforming 70.59% of the companies in the same industry.
A Debt/Equity ratio of 0.01 indicates that BRIA is not too dependend on debt financing.
BRIA has a Debt to Equity ratio of 0.01. This is in the better half of the industry: BRIA outperforms 64.71% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z 5.76
ROIC/WACC5.49
WACC9%
BRIA Yearly LT Debt VS Equity VS FCFBRIA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 0 2M 4M 6M 8M 10M

2.3 Liquidity

BRIA has a Current Ratio of 1.33. This is a normal value and indicates that BRIA is financially healthy and should not expect problems in meeting its short term obligations.
BRIA's Current ratio of 1.33 is on the low side compared to the rest of the industry. BRIA is outperformed by 70.59% of its industry peers.
BRIA has a Quick Ratio of 1.33. This is a bad value and indicates that BRIA is not financially healthy enough and could expect problems in meeting its short term obligations.
BRIA has a Quick ratio of 0.96. This is comparable to the rest of the industry: BRIA outperforms 47.06% of its industry peers.
Industry RankSector Rank
Current Ratio 1.33
Quick Ratio 0.96
BRIA Yearly Current Assets VS Current LiabilitesBRIA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 5M 10M 15M 20M 25M

1

3. Growth

3.1 Past

BRIA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -24.65%.
The Revenue has grown by 8.03% in the past year. This is quite good.
EPS 1Y (TTM)-24.65%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-24.65%
Revenue 1Y (TTM)8.03%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%8.03%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
BRIA Yearly Revenue VS EstimatesBRIA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 20M 40M 60M

1

4. Valuation

4.1 Price/Earnings Ratio

BRIA is valuated quite expensively with a Price/Earnings ratio of 25.50.
Compared to the rest of the industry, the Price/Earnings ratio of BRIA is on the same level as its industry peers.
BRIA's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 28.18.
Industry RankSector Rank
PE 25.5
Fwd PE N/A
BRIA Price Earnings VS Forward Price EarningsBRIA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

BRIA's Enterprise Value to EBITDA ratio is in line with the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 16.87
BRIA Per share dataBRIA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5

4.3 Compensation for Growth

The decent profitability rating of BRIA may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for BRIA!.
Industry RankSector Rank
Dividend Yield N/A

BRILLIA INC-A

NYSEARCA:BRIA (5/2/2025, 8:04:03 PM)

2.55

+0.28 (+12.33%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustryDistributors
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.02%
Inst Owner ChangeN/A
Ins Owners90%
Ins Owner ChangeN/A
Market Cap78.08M
AnalystsN/A
Price TargetN/A
Short Float %0.06%
Short Ratio0.06
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 25.5
Fwd PE N/A
P/S 1.4
P/FCF N/A
P/OCF N/A
P/B 10.88
P/tB 10.88
EV/EBITDA 16.87
EPS(TTM)0.1
EY3.92%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS1.82
BVpS0.23
TBVpS0.23
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 11.94%
ROE 43.85%
ROCE 59.59%
ROIC 49.37%
ROICexc 279.42%
ROICexgc 279.42%
OM 7.67%
PM (TTM) 5.64%
GM 44.89%
FCFM N/A
ROA(3y)16.06%
ROA(5y)N/A
ROE(3y)52.81%
ROE(5y)N/A
ROIC(3y)55.82%
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)67.27%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover2.12
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Debt/EBITDA 0.01
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.33
Quick Ratio 0.96
Altman-Z 5.76
F-Score3
WACC9%
ROIC/WACC5.49
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-24.65%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-24.65%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)8.03%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%8.03%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-17.56%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-101.61%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-101.61%
OCF growth 3YN/A
OCF growth 5YN/A